Matias A. Bustos, PhD

Matias A. Bustos, PhD

Assistant Professor
St. John’s Cancer Institute
Santa Monica, California

Abstract 3233. Interleukin enhancer-binding factor 2 amplification controls mRNA stability and enhances DNA damage response in metastatic melanoma.

What are your long-term career objectives? 

My research goals are: 1) to improve the early detection of solid tumors; 2) to develop new potential blood and tissue biomarkers for monitoring treatment; and 3) to unravel regulatory pathways promoting drug resistance and tumor progression. My long-term career objectives are to become a thought leader in research and utilize the knowledge to improve molecular precision oncology to develop new strategies for earlier diagnosis as well as advance in the characterization of treatment predictors.

Please share information about how the COVID-19 pandemic has impacted your research over the last two years. 

Over the last two years of the COVID-19 pandemic, as part of the healthcare system, our Institute was never shut down and thus, allowed us to keep on working and performing oncological research. This represented a major challenge to keep people safe and healthy. Fortunately, our team surpassed all the difficulties that COVID-19 imposed and the adversity. During the last two years, we have completed many projects with the envision of improving precision oncology and patients’ health care.